p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease with few treatment options other than renal replacement therapy. p21, a cyclin kinase inhibitor which has pleiotropic effects on the cell cycle, in many cases acts to suppress cell cycle progression and to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin-Young, Schutzer, William E, Lindsley, Jessie N, Bagby, Susan P, Oyama, Terry T, Anderson, Sharon, Weiss, Robert H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045080/
https://www.ncbi.nlm.nih.gov/pubmed/17714589
http://dx.doi.org/10.1186/1471-2369-8-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045080/
https://www.ncbi.nlm.nih.gov/pubmed/17714589
http://dx.doi.org/10.1186/1471-2369-8-12

Ejemplares similares